(Q48609216)

13 February 2018

title

Current patterns of irritable bowel syndrome in Taiwan: the Rome II questionnaire on a Chinese population. (English)

1 reference

13 February 2018

1 reference

irritable bowel syndrome

1 reference

Lu CL

1

1 reference

13 February 2018

Chen CY

2

1 reference

13 February 2018

Lang HC

3

1 reference

13 February 2018

Luo JC

4

1 reference

13 February 2018

Wang SS

5

1 reference

13 February 2018

Chang FY

6

1 reference

13 February 2018

Lee SD

7

1 reference

13 February 2018

language of work or name

English

0 references

publication date

1 December 2003

1 reference

13 February 2018

Alimentary Pharmacology & Therapeutics

published in

1 reference

13 February 2018

volume

18

1 reference

13 February 2018

issue

11-12

1 reference

13 February 2018

page(s)

1159-1169

1 reference

13 February 2018

Irritable bowel syndrome: pathogenesis and management

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01711.X

A comparison of the Rome and Manning criteria for case identification in epidemiological investigations of irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01711.X

Functional gastrointestinal disorders in Canada: first population-based survey using Rome II criteria with suggestions for improving the questionnaire

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01711.X

Irritable bowel syndrome according to varying diagnostic criteria: are the new Rome II criteria unnecessarily restrictive for research and practice?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01711.X

A population study on irritable bowel syndrome and mental health

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01711.X

Irritable bowel syndrome prevalence varies enormously depending on the employed diagnostic criteria: comparison of Rome II versus previous criteria in a general population

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01711.X

Costs of care for irritable bowel syndrome patients in a health maintenance organization

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01711.X

The IBS-36: a new quality of life measure for irritable bowel syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01711.X

Subjective and objective sleep quality in irritable bowel syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01711.X

Irritable bowel syndrome in a rural community in Bangladesh: prevalence, symptoms pattern, and health care seeking behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01711.X

Prevalence of irritable bowel syndrome in Hong Kong

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01711.X

Public awareness, attitude, and understanding of epilepsy in Hong Kong Special Administrative Region, China.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01711.X

The epidemiology of irritable bowel syndrome in North America: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01711.X

Epidemiology of cholecystectomy and irritable bowel syndrome in a UK population

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01711.X

The irritable bowel syndrome: long-term prognosis and the physician-patient interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01711.X

10.1046/J.1365-2036.2003.01711.X

21 January 2018

Identifiers

DOI

1 reference

13 February 2018

PubMed ID

14653836

1 reference

13 February 2018